Skip to main content
SpringerLink
Log in

Ampicillin/sulbactam/favipiravir

Lack of efficacy following off-label use: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Al Bishawi A, et al. Dilemma of Tocilizumab therapy for a patient with critical COVID-19 disease and neutropenia: Case report and review of the literature. Clinical Case Reports 10: 1-6, No. 5, 27 May 2022. Available from: URL: http://doi.org/10.1002/ccr3.5932

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ampicillin/sulbactam/favipiravir. Reactions Weekly 1918, 41 (2022). https://doi.org/10.1007/s40278-022-20498-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-20498-5

Search

Navigation